Nanomedicines: Targeting inflammatory pathway in cancer and aging

Semin Cancer Biol. 2022 Nov;86(Pt 2):1218-1221. doi: 10.1016/j.semcancer.2022.10.008. Epub 2022 Oct 28.

Authors

Olga A Sukocheva¹, Yonggang Zhang²

Affiliations

¹ College of Nursing and Health Sciences, Flinders University, Bedford Park 5042, South Australia, Australia; Department of Hepatology, Royal Adelaide Hospital, SA Health, Adelaide 5000, South Australia, Australia. Electronic address: olga.sukocheva@flinders.edu.au.
² West China Hospital, Sichuan University, Chengdu 610041, China. Electronic address: jebm_zhang@yahoo.com.

PMID: 36341801
DOI: 10.1016/j.semcancer.2022.10.008

No abstract available

Publication types

Editorial

MeSH terms

Aging / genetics
Antineoplastic Agents* / therapeutic use
Drug Delivery Systems
Humans
Nanomedicine
Neoplasms* / drug therapy

Substances

Antineoplastic Agents